基于RNA的治疗技术
Ryuichi Mashima1, Shuji Takada2, Yoshitaka Miyamoto3
1Department of Clinical Laboratory Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo 157-8535, Japan.
International journal of molecular sciences
|October 28, 2023
概括
基于RNA的疗法为基于DNA的基因疗法提供了一种较温和的替代方案,通过更好地控制基因表达来治疗癌症,血液疾病和遗传性疾病.
科学领域:
- 生物技术是生物技术.
- 分子生物学分子生物学
- 免疫治疗是一种免疫疗法.
背景情况:
- 在COVID-19后,基于RNA的疗法正在获得引力,与已建立的基于DNA的基因疗法如AAV和lentivirus载体形成鲜明对比.
- 基于DNA的疗法提供持续的表达,但缺乏精确的控制,可能导致诸如癌症免疫治疗中的细胞因子释放综合征等不良影响.
- 在微调基因表达至关重要的地方,医疗需求仍未得到满足,这凸显了当前基于DNA的方法的局限性.
研究的目的:
- 审查基于RNA的疗法的临床应用和潜力.
- 将基于RNA的疗法与基于DNA的基因疗法进行比较,重点关注控制和安全.
- 探索基于RNA的疗法在癌症免疫疗法,造血性疾病和遗传性疾病中的作用.
主要方法:
- 关于基于RNA和基于DNA的治疗策略的最新进展的文献综述.
- 在RNA和DNA模式之间对基因表达控制和治疗疗效的比较分析.
- 对瘤学,血液学和遗传疾病的临床研究进行专注的检查.
主要成果:
- 基于RNA的疗法比基于DNA的基因疗法提供了更可控和潜在的更安全的替代方案.
- 调节基因表达的能力在管理诸如癌症免疫疗法诱导的细胞因子释放综合征等疾病方面具有优势.
- RNA疗法对各种应用具有前景,包括造血和遗传性疾病.
结论:
- 基于RNA的疗法是一个正在发展的领域,具有很大的潜力来解决基于DNA的基因疗法的局限性.
- 它的可调节性使其适用于需要精确基因表达控制的应用,例如免疫疗法和遗传疾病.
- 对基于RNA的疗法进行进一步的研究对于各种临床应用是有必要的.
更多相关视频
07:43Author Spotlight: Addressing Regulatory Gaps in Molecular Studies by Quantifying Viral Vectors in Complex Matrices
Published on: July 14, 2023
2.0K
06:10Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
283
相关概念视频
Microorganisms in Medicine and Therapeutics
35
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
35
Gene Therapy
25.4K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.4K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Recombinant DNA
95.6K
Overview
95.6K
Tumor Immunotherapy
538
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
538
siRNA - Small Interfering RNAs
16.8K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.8K
